Summary
Updated Aug 31, 2026
Marshall H. Woodworth is Chief Financial Officer of MetaVia Inc. (MTVA). 2 SEC Form 4 filings on record going back to 2025, most recently on 27 January 2026.
Recent Transactions
2Every recent SEC Form 4 transaction Marshall H. Woodworth has reported, most recent first.
Other Insiders Active in the Same Sector
No other insider has filed at Marshall H. Woodworth's companies, so these are insiders reporting open-market trades at other companies in the same sector.
- Jonathan M. Rothberg - $62.19M of BFLY open-market activity in the last 12 months
- Jeffrey M. Leiden - $60.94M of VRTX open-market activity in the last 12 months
- Vivek Ramaswamy - $60.40M of ROIV open-market activity in the last 12 months
- David Cordani - $60.11M of CI open-market activity in the last 12 months
- BAKER BROS. ADVISORS LP - $60.00M of KOD open-market activity in the last 12 months
- Deep Track Biotechnology Master Fund, Ltd. - $60.00M of LBRX open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Marshall H. Woodworth?
Marshall H. Woodworth is a corporate insider, tracked as Chief Financial Officer of MetaVia Inc. (MTVA). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Marshall H. Woodworth last file a Form 4?
The most recent primary Form 4 on record is dated 27 January 2026, one of 2 filings going back to 2025.
Where can I see all of Marshall H. Woodworth's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Marshall H. Woodworth and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
